Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edwards Lifesciences Corp (EW) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Edwards Lifesciences Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1099800.
Total stock buying since 2015: $2,320,964.
Total stock sales since 2015: $955,812,098.
Total stock option exercises since 2015: $269,667,795.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 147,070 | $10,880,959 | 121,833 | $5,766,927 |
| 2024 | 580 | $49,730 | 436,617 | $36,821,216 | 443,141 | $15,365,052 |
| 2023 | 0 | $0 | 776,089 | $62,525,471 | 866,651 | $31,038,662 |
| 2022 | 0 | $0 | 722,684 | $73,906,699 | 972,597 | $23,063,224 |
| 2021 | 1,500 | $168,345 | 1,052,239 | $103,810,080 | 1,416,122 | $24,477,104 |
| 2020 | 0 | $0 | 1,262,598 | $128,977,831 | 1,566,127 | $30,035,920 |
| 2019 | 0 | $0 | 659,193 | $130,721,340 | 729,376 | $27,492,262 |
| 2018 | 0 | $0 | 888,652 | $124,048,601 | 871,925 | $32,595,505 |
| 2017 | 3,000 | $270,300 | 874,538 | $93,390,028 | 973,747 | $31,725,623 |
| 2016 | 20,870 | $1,832,589 | 1,079,098 | $105,613,525 | 1,213,936 | $28,166,951 |
| 2015 | 0 | $0 | 629,600 | $85,116,348 | 638,465 | $19,940,565 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-01 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 100.64 | 728,827 |
| 2022-06-01 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-05-31 | Zovighian Bernard J (CVP, TMTT) | Sale | 9,000 | 100.83 | 907,488 |
| 2022-05-26 | Chopra Daveen (CVP, Surgical Structural Heart) | Sale | 1,000 | 98.31 | 98,312 |
| 2022-05-24 | Zovighian Bernard J (CVP, TMTT) | Sale | 4,809 | 95.52 | 459,355 |
| 2022-05-10 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 96.04 | 695,550 |
| 2022-05-10 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-05-10 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 94.86 | 3,087,855 |
| 2022-05-10 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2022-05-09 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Sale | 11,560 | 98.25 | 1,135,712 |
| 2022-05-09 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Option Ex | 11,560 | 21.76 | 251,545 |
| 2022-05-09 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 3,675 | 98.71 | 362,759 |
| 2022-05-09 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 3,675 | 35.20 | 129,348 |
| 2022-05-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 98.71 | 663,824 |
| 2022-05-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-05-08 | Chopra Daveen (CVP, Surgical Structural Heart) | Option Ex | 8,531 | .00 | 0 |
| 2022-05-08 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Option Ex | 8,531 | .00 | 0 |
| 2022-05-08 | Zovighian Bernard J (CVP, TMTT) | Option Ex | 12,600 | .00 | 0 |
| 2022-05-08 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 14,831 | .00 | 0 |
| 2022-05-08 | Wood Larry L (CVP, TAVR) | Option Ex | 13,256 | .00 | 0 |
| 2022-05-08 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 12,206 | .00 | 0 |
| 2022-05-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,956 | .00 | 0 |
| 2022-05-08 | Mussallem Michael A (Chairman & CEO) | Option Ex | 56,831 | .00 | 0 |
| 2022-05-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 12,600 | .00 | 0 |
| 2022-05-04 | Szyman Catherine M. (CVP, Critical Care) | Sale | 23,400 | 105.05 | 2,458,193 |
| 2022-05-04 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 23,400 | 21.76 | 509,184 |
| 2022-04-29 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 107.88 | 3,511,624 |
| 2022-04-29 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2022-04-28 | Marsh Martha H. (Director) | Sale | 28,722 | 108.09 | 3,104,560 |
| 2022-04-28 | Marsh Martha H. (Director) | Option Ex | 28,722 | 25.99 | 746,427 |
| 2022-04-11 | Szyman Catherine M. (CVP, Critical Care) | Sale | 20,000 | 122.16 | 2,443,260 |
| 2022-04-11 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 20,000 | 21.76 | 435,200 |
| 2022-04-08 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Sale | 11,660 | 123.43 | 1,439,205 |
| 2022-04-08 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Option Ex | 11,660 | 21.76 | 253,721 |
| 2022-04-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 3,675 | 123.07 | 452,282 |
| 2022-04-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 3,675 | 35.20 | 129,348 |
| 2022-04-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 123.21 | 1,361,503 |
| 2022-04-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2022-04-05 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 121.30 | 878,454 |
| 2022-04-05 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-03-22 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 111.39 | 3,625,907 |
| 2022-03-22 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2022-03-14 | Szyman Catherine M. (CVP, Critical Care) | Sale | 20,000 | 104.60 | 2,091,940 |
| 2022-03-14 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 20,000 | 21.76 | 435,200 |
| 2022-03-11 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Sale | 11,660 | 106.06 | 1,236,647 |
| 2022-03-11 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Option Ex | 11,660 | 21.76 | 253,721 |
| 2022-03-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 106.03 | 1,171,631 |
| 2022-03-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2022-03-08 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 106.38 | 770,389 |
| 2022-03-08 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-03-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 3,675 | 107.60 | 395,430 |
| 2022-03-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 3,675 | 35.20 | 129,348 |
| 2022-02-18 | Szyman Catherine M. (CVP, Critical Care) | Sale | 20,000 | 106.18 | 2,123,520 |
| 2022-02-18 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 20,000 | 21.76 | 435,200 |
| 2022-02-15 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 110.28 | 3,589,451 |
| 2022-02-15 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2022-02-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 111.73 | 1,234,638 |
| 2022-02-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2022-02-08 | Wood Larry L (CVP, TAVR) | Sale | 4,386 | 109.90 | 482,034 |
| 2022-02-08 | Wood Larry L (CVP, TAVR) | Option Ex | 4,386 | 36.75 | 161,185 |
| 2022-02-08 | Gallahue Kieran (Director) | Sale | 32,256 | 110.79 | 3,573,513 |
| 2022-02-08 | Gallahue Kieran (Director) | Option Ex | 32,256 | 22.29 | 718,889 |
| 2022-02-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 110.20 | 699,770 |
| 2022-02-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2022-01-28 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 100.47 | 1,110,226 |
| 2022-01-28 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2022-01-14 | Szyman Catherine M. (CVP, Critical Care) | Sale | 10,000 | 119.74 | 1,197,390 |
| 2022-01-14 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 10,000 | 21.76 | 217,600 |
| 2022-01-07 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 122.16 | 775,716 |
| 2022-01-07 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2022-01-06 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 124.37 | 4,048,243 |
| 2022-01-06 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-12-20 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 119.28 | 3,882,466 |
| 2021-12-20 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-12-17 | Szyman Catherine M. (CVP, Critical Care) | Sale | 10,000 | 121.24 | 1,212,400 |
| 2021-12-17 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 10,000 | 21.76 | 217,600 |
| 2021-12-10 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 121.49 | 951,266 |
| 2021-12-10 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-12-10 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 121.75 | 773,131 |
| 2021-12-10 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-12-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 121.75 | 1,345,381 |
| 2021-12-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-11-29 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Sale | 100 | 110.58 | 11,058 |
| 2021-11-29 | Lemercier Jean-luc M (CVP, EMEA, Canada, Latin Amer) | Option Ex | 100 | 21.76 | 2,176 |
| 2021-11-24 | Valeriani Nicholas J (Director) | Buy | 1,500 | 112.23 | 168,345 |
| 2021-11-18 | Szyman Catherine M. (CVP, Critical Care) | Sale | 10,000 | 117.91 | 1,179,130 |
| 2021-11-18 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 10,000 | 21.76 | 217,600 |
| 2021-11-10 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 119.79 | 937,955 |
| 2021-11-10 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-11-09 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 119.94 | 3,903,884 |
| 2021-11-09 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-11-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 119.40 | 758,190 |
| 2021-11-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-11-05 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 117.24 | 1,295,524 |
| 2021-11-05 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-10-18 | Szyman Catherine M. (CVP, Critical Care) | Sale | 9,741 | 110.56 | 1,076,916 |
| 2021-10-18 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 9,741 | 21.76 | 211,964 |
| 2021-10-11 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 108.00 | 845,640 |
| 2021-10-11 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-10-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 110.91 | 704,278 |
| 2021-10-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-10-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 110.77 | 1,223,986 |
| 2021-10-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-10-01 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 112.20 | 3,652,207 |
| 2021-10-01 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-09-15 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 120.91 | 3,935,620 |
| 2021-09-15 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-09-10 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 122.59 | 959,879 |
| 2021-09-10 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-09-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 122.50 | 1,353,569 |
| 2021-09-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-09-08 | Szyman Catherine M. (CVP, Critical Care) | Sale | 9,741 | 121.28 | 1,181,359 |
| 2021-09-08 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 9,741 | 21.76 | 211,964 |
| 2021-09-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 121.25 | 769,950 |
| 2021-09-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-08-10 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 114.14 | 893,677 |
| 2021-08-10 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-08-09 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 115.54 | 733,679 |
| 2021-08-09 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-08-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 114.37 | 1,263,766 |
| 2021-08-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-08-03 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 114.11 | 3,714,117 |
| 2021-08-03 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-08-02 | Szyman Catherine M. (CVP, Critical Care) | Sale | 15,000 | 113.53 | 1,702,905 |
| 2021-08-02 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 15,000 | 21.76 | 326,400 |
| 2021-07-12 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 107.48 | 841,568 |
| 2021-07-12 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-07-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 108.16 | 1,195,112 |
| 2021-07-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-07-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 106.72 | 677,672 |
| 2021-07-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-07-01 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 104.61 | 3,404,892 |
| 2021-07-01 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-06-15 | Szyman Catherine M. (CVP, Critical Care) | Sale | 3,410 | 101.17 | 344,989 |
| 2021-06-15 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 3,410 | 22.29 | 75,998 |
| 2021-06-15 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 6,350 | 101.00 | 641,369 |
| 2021-06-15 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 6,350 | 21.76 | 138,176 |
| 2021-06-14 | Wood Larry L (CVP, TAVR) | Sale | 7,830 | 99.91 | 782,295 |
| 2021-06-14 | Wood Larry L (CVP, TAVR) | Option Ex | 7,830 | 35.20 | 275,592 |
| 2021-06-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,050 | 99.84 | 1,103,198 |
| 2021-06-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,050 | 21.76 | 240,448 |
| 2021-06-09 | Mussallem Michael A (Chairman & CEO) | Sale | 32,550 | 97.23 | 3,164,836 |
| 2021-06-09 | Mussallem Michael A (Chairman & CEO) | Option Ex | 45,050 | 21.76 | 980,288 |
| 2021-05-28 | Szyman Catherine M. (CVP, Critical Care) | Sale | 2,061 | 95.29 | 196,392 |
| 2021-05-25 | Szyman Catherine M. (CVP, Critical Care) | Sale | 4,665 | 96.09 | 448,259 |
| 2021-05-24 | Mussallem Michael A (Chairman & CEO) | Sale | 33,000 | 95.84 | 3,162,720 |
| 2021-05-24 | Mussallem Michael A (Chairman & CEO) | Option Ex | 33,000 | 21.76 | 718,080 |
| 2021-05-17 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 17,193 | .00 | 0 |
| 2021-05-17 | Wood Larry L (CVP, TAVR) | Option Ex | 16,406 | .00 | 0 |
| 2021-05-17 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 8,662 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of EW listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Edwards Lifesciences Corp (symbol EW, CIK number 1099800) see the Securities and Exchange Commission (SEC) website.